epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Bosulif
    bosutinib
  • remove Remicade
    infliximab
  • remove Vicks NyQuil Cold & Flu
    acetaminophen/ doxylamine/ dextromethorphan
  • remove Xultophy 100/ 3.6
    insulin degludec/ liraglutide

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Bosulif (bosutinib) + Remicade (infliximab)

Monitor/Modify Tx


bosutinib + infliximab

monitor cardiac fxn: combo may incr. risk of cardiotoxicity (additive effects)

Caution Advised

Smiley face Smiley face Vicks NyQuil Cold & Flu (acetaminophen/ doxylamine/ dextromethorphan) + Xultophy 100/3.6 (insulin degludec/ liraglutide)

Caution Advised


acetaminophen + liraglutide

caution advised w/ oral acetaminophen: combo may decr. peak acetaminophen levels, delay analgesic onset, efficacy (absorption delayed, possibly decreased)

Additional Considerations

Smiley face Smiley face infliximab in Remicade

caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs

Smiley face Smiley face dextromethorphan in Vicks NyQuil Cold & Flu

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face liraglutide in Xultophy 100/3.6

caution advised with concurrent oral drugs requiring rapid onset; liraglutide delays gastric emptying

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information